Semaglutide FAQ: Plain Answers From Studies
Semaglutide helped two groups at high heart risk
Yes, but the benefit was shown only in the groups studied. One study followed 17,604 adults who had no diabetes but did have heart disease and excess weight. With Semaglutide 2.4 mg, major heart problems occurred 20% less often [3], and its 95% range supported that result.
SUSTAIN-6, a diabetes heart study, covered people with type 2 diabetes and a serious risk of heart trouble. It found 26% fewer major heart problems [2]. Both studies counted deaths tied to the heart, strokes, and heart attacks.
Semaglutide lowered heart attack and stroke risk in two groups
Yes, for two study groups. Both studies counted heart attack, stroke, and death caused by heart trouble. The larger study found 20% fewer problems among adults already living with heart disease while carrying excess weight [3].
SUSTAIN-6, the diabetes heart study, found 26% fewer problems in people whose type 2 diabetes came with high heart risk. The SUSTAIN-6 report gave a 95% range that also favored the medicine [2]. Neither study proves that everyone will receive the same benefit.
The largest Semaglutide heart study found fewer major problems
The study included 17,604 adults who did not have diabetes and had heart disease. Each had a body mass index of 27 or more, meaning weight was high for height. They received Semaglutide 2.4 mg or placebo, a look-alike treatment holding no medicine.
Stroke, heart attack, or death tied to the heart occurred 20% less often with Semaglutide [3]. The 95% range supported fewer problems, while another check made chance a poor explanation. A 2024 review found the benefit at different starting weights and blood sugar levels [13].
What is Semaglutide: a medicine that copies a gut hormone
Semaglutide is a 31-amino-acid protein; amino acids are small units used to build proteins. It copies GLP-1, a gut-made hormone. You may also hear GLP-1 used for this medicine group [12]. Semaglutide is approved to treat type 2 diabetes, help with weight over time, lower some heart risks, and address a serious liver disease added in 2025.
STEP 1, a weight study, found average weight fell 14.9% after 68 weeks, compared with a 2.4% drop on placebo [1]. Your own result may fall on either side of that average, so the number can’t predict your change.
Semaglutide is used in diabetes, weight, heart, and liver care
Semaglutide is approved to treat type 2 diabetes and help with weight over time. It also lowers certain heart risks for adults already living with heart disease while carrying excess weight. In 2025, use widened to a serious liver disease caused by fat buildup and scarring [12].
A study with 20% fewer major heart problems supports the heart use [3]. STEP 1 supports the weight use in part, with an average drop of 14.9% [1]. Your doctor can tell you whether any use fits your health.
How does Semaglutide work: it lowers hunger and blood sugar
Semaglutide copies GLP-1, which your gut makes and sends out after a meal. When your blood sugar goes up, the medicine prompts your pancreas to move insulin into the blood [12]. It also helps your brain register that you’ve eaten enough while slowing your stomach.
In rats and mice, Semaglutide reached parts of the brain that control hunger. They ate less, yet their energy use did not rise [4]. Those results suggest one reason for weight loss, but they don’t prove every step in people.
How does Semaglutide work for weight loss: mainly by easing hunger
The clearest answer is smaller meals, not faster calorie burning. Rats and mice changed their food choices and ate less while energy use stayed level [4], though animal work can’t prove the full effect in people.
STEP 1 tested the weight result in adults. At 68 weeks, average weight fell 14.9% with Semaglutide and 2.4% with placebo [1]. Your own change could be higher or lower.
Studies raised the Semaglutide dosage for weight loss in stages
Researchers began with a 0.25 mg weekly shot, then raised the amount across about four months to 2.4 mg [12]. STEP 1, the weight study, used that later amount [1].
This Semaglutide dosage comes from research and the medicine label; it isn’t a plan for you. Only your doctor can choose after reviewing your health.
40 units of Semaglutide don’t equal one set amount
There is no single safe way to turn “units” into milligrams for Semaglutide. Approved pens give set amounts, such as 2.4 mg, instead of a volume that you measure [12]. Compounded products, meaning medicine prepared at a pharmacy, may use “units.” Wrong amounts have been reported [5].
A number on one container may mean something different on another. We don’t give those conversions. Your pharmacist can read the exact label on your container.
Compounded Semaglutide was mixed by pharmacies during a shortage
A pharmacy prepares compounded Semaglutide instead of the company that makes the approved medicine. Temporary rules allowed this during a shortage. Reports described hospital stays, mistakes in the amount, and unchecked main ingredients [5].
The shortage ended in 2025, so officials ended much of that temporary permission [12]. Because large studies used the approved medicine, they can’t show that a pharmacy-made version will act the same way.
Semaglutide side effects most often involve the stomach
About one person in three had nausea in the review. Constipation, vomiting, and diarrhea were also common, mostly while researchers raised the amount [5]. Gallstones and other gallbladder trouble were more frequent as well.
In SUSTAIN-6, a diabetes heart study, quick drops in blood sugar were linked with extra eye trouble [5][2]. Your risk may differ from someone else’s. The effects page keeps study findings apart from personal reports.
Semaglutide works over weeks, not at one set hour
The studies show a slow build rather than one clear starting hour. Researchers raised the amount over weeks to limit stomach trouble. STEP 1, the weight study, found average weight fell 14.9% by week 68 [1].
Weight came off across that time instead of all at once, while blood sugar also changed over weeks in diabetes studies. No study names one day when everyone notices an effect.
Semaglutide remains in the body for about five weeks
Half-life is the time needed for half the medicine to leave your body. For Semaglutide, the half-life is about one week, and some medicine stays for about five weeks [12]. A main blood protein carries it. The medicine also resists DPP-4, a body substance that would otherwise clear it too soon [12].
Because the medicine stays so long, timing matters when someone plans a pregnancy. The label calls for a waiting period before pregnancy [17], which your doctor can explain for your care.
Semaglutide has a half-life of about one week
About one week is the half-life, often listed as 165-168 hours [12], meaning half the medicine leaves during that time. About five weeks pass before nearly all of the final amount is gone.
A fat-like part lets a blood protein carry Semaglutide. Another part, marked as number 8 in the lab, resists DPP-4, a body substance that would otherwise clear it too fast [12]. Both changes help the medicine last.
Oral Semaglutide and the injection aren’t a simple match
A heart study called PIONEER 6 found oral Semaglutide was at least as safe as placebo for major heart problems in diabetes [8]. Fewer deaths occurred with the tablet, but the study didn’t prove cause. It did not compare the tablet with the shot.
Only about 0.4-1% of the tablet reaches your blood [12]. The amounts and reasons for use also differ, so there isn’t one plain yes-or-no answer for you.
Semaglutide may ease hunger early, but studies didn’t time it
Some people say hunger eases early and changes more as the amount rises. In rats and mice, Semaglutide reached parts of the brain that control hunger and reduced how much they ate [4]. That work was not done in people.
Studies in people tracked weight over weeks. They didn’t record the first hour when hunger changed. There isn’t one proven waiting time for you.
Weight loss with Semaglutide differs from person to person
A study average can’t predict your own change. STEP 1, the weight study, found average loss of 14.9% at 68 weeks [1]. Some people lost more, others less, and the pace tended to slow.
Weight also came back for many after treatment ended [19]. A web page can’t explain your own result, but your doctor can look at your health, medicines, and recent changes.
Some people using Semaglutide describe tiredness
Some people describe low energy soon after a shot, then say the tired feeling often eases after the early weeks [3]. These personal accounts were not checked in a formal study that compared groups.
Studies recorded stomach and bowel problems more often than tiredness [5]. One person’s report can’t show that Semaglutide was the cause. The effects page keeps those accounts separate from study results.
Semaglutide copies a gut hormone called GLP-1
Yes. Semaglutide was made to copy GLP-1, a natural hormone from your gut [12]. Its protein is a 94% match for the GLP-1 hormone, though the medicine remains active far longer.
GLP-1 works in the brain, gut, and pancreas [12], helping guide hunger, stomach speed, and blood sugar. The name describes what Semaglutide copies; the medicine isn’t the natural hormone itself.
Hair shedding may follow fast weight loss with Semaglutide
Reports have linked Semaglutide with hair shedding, without proving a direct cause [15][16]. Fast, large weight loss may push more hair into a resting stage, and hair lost this way often grows back.
One review found extra hair-loss reports for Semaglutide and tirzepatide [15]. Another study tied shedding to how fast weight came off [16]. The cause is suggested, not proven.
Semaglutide is meant to build its effect slowly
Researchers raised the amount over weeks to limit stomach trouble [5], so the effect built over time. STEP 1, the weight study, recorded average loss of 14.9% at week 68 [1].
The study did not name one quick starting point. Semaglutide also remains active for about a week [12], supporting gradual change rather than an overnight effect.
Semaglutide vs tirzepatide: more weight came off with tirzepatide
The medicines don’t copy the same mix of gut hormones. A direct weight study called SURMOUNT-5 included 751 adults with extra weight. At 72 weeks, average weight fell 20.2% with tirzepatide and 13.7% with Semaglutide [21].
A study check found chance was a poor fit for that gap. For major heart problems, Semaglutide has a large study that found a 20% drop [3]. Each medicine has different strengths in the studies now available.